Mobile devices and apps are increasingly becoming integrated into the healthcare continuum. Physicians use smartphones at work and recommend apps to their patients, hospitals use data generated through smartphone apps to keep tabs on patients with chronic conditions and consumers…

From 2012 to 2013, hospitals reported overall increases in patient engagement electronic health record functionalities, according to a report from the ONC.

The global e-prescribing market is projected to be valued at $887.8 million in 2019, growing at a compound annual growth rate of 23.5 percent, according to a Transparency Market Research news release.

The use of robotics has gained popularity in recent years partly due to its minimally invasive surgery capabilities and potential for improved outcomes. From 2005 to 2012, the use of robotics in the United States jumped from 25,000 cases per…

The U.S. Food and Drug Administration maintains a list of types of mobile apps the FDA could possibly regulate under the department's regulation framework, but for which it has chosen to exercise discretion.

Planned Parenthood of the Heartland is suing the Iowa Board of Medicine, which last year banned a telemedicine abortion system, saying the ban increases the woman's medical risk, according to a report by The Des Moines Register.

Renown Health in Reno, Nev., has retained executive search firm B. E. Smith to find the organization's next CIO.

The American Telemedicine Association and the Health IT Now Coalition have written to the House Energy & Commerce Health Subcomittee, renewing the call for Congress to remove regulatory barriers to the practice of telemedicine.

The American Hospital Association has written a letter to CMS Administrator Marilyn Tavenner and National Coordinator Karen DeSalvo, MD, asking the departments to quickly adopt a proposed rule that would allow providers that have encountered vendor delays additional flexibility in…

Medical device and pharmaceutical companies must include risk information along with benefit claims in all online postings about their products, even when Twitter limits them to 140 characters, according to new draft guidance from the U.S. Food and Drug Administration.